Initial Treatment for Acid Peptic Disease

Diagnostic Considerations

The American Gastroenterological Association recommends that before initiating treatment, clinicians should assess for alarm symptoms (dysphagia, bleeding, anemia, weight loss, recurrent vomiting) which would warrant immediate endoscopic evaluation 1
In patients without alarm symptoms, empiric PPI therapy is appropriate as initial management, according to the American Gastroenterological Association 2

The American College of Gastroenterology recommends beginning with a standard dose of PPI once daily, taken 30-60 minutes before a meal for optimal efficacy 2
Any commercially available PPI can be used (omeprazole, lansoprazole, pantoprazole, rabeprazole, esomeprazole, dexlansoprazole) as absolute differences in efficacy for symptom control are small, as stated by the American Gastroenterological Association 2
PPIs are more effective than histamine-2 receptor antagonists (H2RAs), which are in turn more effective than placebo, according to the American Gastroenterological Association 2
The initial treatment duration should be 4-8 weeks, as recommended by the American College of Gastroenterology 3, 2

The American Gastroenterological Association recommends providing standardized educational material on disease mechanisms, weight management, and dietary behaviors 3
Elevation of the head of the bed for nighttime symptoms is recommended by the American College of Gastroenterology 3
Avoidance of trigger foods (alcohol, coffee, spicy foods, carbonated beverages) is recommended by the American College of Gastroenterology 3
Weight loss for overweight or obese patients is recommended by the American College of Gastroenterology 3

If symptoms persist after 4-8 weeks of once-daily PPI therapy, consider increasing to twice-daily PPI dosing, as recommended by the American College of Gastroenterology 3, 4
Switching to a more potent acid suppressive agent may be considered, according to the American College of Gastroenterology 3, 4
Adding adjunctive therapy based on symptom phenotype may be considered, such as alginate antacids for breakthrough symptoms, as recommended by the American Gastroenterological Association 5

If symptoms resolve with initial therapy, taper PPI to the lowest effective dose, as recommended by the American College of Gastroenterology 3, 6
If symptoms persist despite optimized PPI therapy (twice daily for 8 weeks), endoscopy is indicated, according to the American Gastroenterological Association 3, 1
For patients with documented severe erosive esophagitis (Los Angeles grade B or worse), follow-up endoscopy after 8 weeks of PPI therapy is recommended to ensure healing, as stated by the American College of Physicians 1
If long-term PPI therapy is planned, objective reflux testing should be considered to confirm the diagnosis, according to the American Gastroenterological Association 5

Failing to assess for alarm symptoms that would warrant immediate endoscopy is a common pitfall, as stated by the American College of Physicians 1
Not optimizing PPI dosing (taking without regard to meals) is a common pitfall, according to the American Gastroenterological Association 2
Continuing empiric PPI therapy long-term without confirming the diagnosis in patients who don't respond adequately is a common pitfall, as recommended by the American Gastroenterological Association 5

For patients with GERD and regurgitation still experiencing symptoms on Rabeprazole 20mg daily, the next step should be to increase the PPI dose to twice daily (morning and evening) before meals, as recommended by the American Gastroenterological Association 7, 8
Before escalating therapy, confirm proper administration of current PPI (30-60 minutes before a meal) to optimize efficacy, according to the American College of Physicians 8

Increase rabeprazole to twice daily dosing (20mg twice daily) for 4-8 weeks, as suggested by the American Gastroenterological Association 7, 8
For regurgitation-predominant symptoms, add a prokinetic agent such as metoclopramide, as recommended by the American Gastroenterological Association 7
For breakthrough symptoms, add alginate-containing antacids, as suggested by the American Gastroenterological Association 7

If symptoms persist after 4-8 weeks of optimized therapy, proceed with ambulatory 24-hour pH-impedance monitoring while on PPI therapy, as recommended by the American Gastroenterological Association 7
Endoscopic evaluation is indicated to assess for refractory erosive disease, complications, or alternative diagnoses, according to the American College of Physicians 8
Consider esophageal manometry to evaluate for motility disorders that may contribute to symptoms, as suggested by the American Gastroenterological Association 7

For patients with proven GERD and persistent regurgitation despite optimized medical therapy, consider referral for anti-reflux procedures, such as laparoscopic fundoplication and magnetic sphincter augmentation, as recommended by the American Gastroenterological Association 7
Endoscopic options include transoral incisionless fundoplication in carefully selected patients, as suggested by the American Gastroenterological Association 7

Not considering non-acid reflux as a cause of persistent regurgitation symptoms, as noted by the American Gastroenterological Association 7
Proceeding with invasive treatments without objective confirmation of GERD diagnosis, as cautioned by the American Gastroenterological Association 7

Regular aerobic exercise has been shown to improve symptoms in patients with acid peptic disease 9